Related Experiment Video
Updated: Jun 20, 2026
11:49
Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
Published on: April 3, 2026
Waiting time to lymph node biopsy is dependent on referral method: don't write, phone!
S A J Pannick1, C L Ingham Clark
1Department of Surgery, Whittington Hospital, London, UK.
Annals of the Royal College of Surgeons of England
|September 30, 2009
Summary
Direct referral for lymph node biopsy significantly reduces patient wait times compared to traditional written referrals, improving diagnostic efficiency for potential malignancy. This study advocates for a fast-track pathway for expedited patient care.
Area of Science:
- Surgical Oncology
- Diagnostic Pathology
- Healthcare Management
Background:
- Lymphadenopathy diagnosis commonly involves surgical lymph node biopsy.
- Long wait times for diagnostic lymph node biopsy services are a concern.
- Optimizing referral pathways is crucial for timely patient management.
Purpose of the Study:
- To compare the efficiency of written versus direct referral methods for diagnostic lymph node biopsy.
- To identify the optimal care pathway for patients with lymphadenopathy.
- To reduce waiting times for lymph node biopsy procedures.
Main Methods:
- Retrospective review of 60 patients over 2 years (excluding breast-related referrals).
- Analysis of referral source, method, waiting time, clinic attendance, and diagnosis using Hospital Episode Statistics.
- Comparison of waiting times between direct personal referral and written referrals.
Main Results:
- Direct personal referral (discussion, email, fax) resulted in a mean wait of 4 days, versus 51 days for written referrals.
- Neoplasia was diagnosed in 43% of biopsies, and infection in 10%.
- Referral source: 33% from hematology, 28% from general practice; 47% were by letter.
Conclusions:
- Direct personal requests expedite lymph node biopsy, significantly reducing wait times.
- A fast-track pathway for lymph node biopsy requests is recommended due to high malignancy rates (43%).
- Implementation of a fast-track pathway has been initiated based on study findings.
